LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 75 of 166
Next
>>
>
1851 to 1875 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MDA-MB-231	PI103	0.37	uM	LJP6	0.5356	0.0819	0.4198	0.1463
MDA-MB-231	PI103	1.11	uM	LJP6	0.4871	0.0380	0.3714	0.0717
MDA-MB-231	PI103	3.33	uM	LJP6	0.4373	0.0612	0.2914	0.1070
MDA-MB-231	PI103	10	uM	LJP6	0.3187	0.0498	0.0948	0.1051
MDA-MB-231	Dovitinib	0.04	uM	LJP5	0.9094	0.0577	0.9028	0.0621
MDA-MB-231	Dovitinib	0.12	uM	LJP5	0.8318	0.0704	0.8165	0.0783
MDA-MB-231	Dovitinib	0.37	uM	LJP5	0.5990	0.0439	0.5336	0.0584
MDA-MB-231	Dovitinib	1.11	uM	LJP5	0.5380	0.0484	0.4507	0.0688
MDA-MB-231	Dovitinib	3.33	uM	LJP5	0.4614	0.0226	0.3427	0.0390
MDA-MB-231	Dovitinib	10	uM	LJP5	0.3900	0.0312	0.2301	0.0569
MDA-MB-231	GSK 690693	0.04	uM	LJP5	0.8696	0.0470	0.8600	0.0511
MDA-MB-231	GSK 690693	0.12	uM	LJP5	0.9090	0.0113	0.9039	0.0121
MDA-MB-231	GSK 690693	0.37	uM	LJP5	0.9111	0.0120	0.9062	0.0120
MDA-MB-231	GSK 690693	1.11	uM	LJP5	0.9428	0.0148	0.9397	0.0151
MDA-MB-231	GSK 690693	3.33	uM	LJP5	1.0078	0.0178	1.0079	0.0183
MDA-MB-231	GSK 690693	10	uM	LJP5	0.8780	0.0401	0.8689	0.0460
MDA-MB-231	SNS-032	0.04	uM	LJP6	0.4478	0.0511	0.3143	0.0627
MDA-MB-231	SNS-032	0.12	uM	LJP6	0.1739	0.0306	-0.2011	0.0950
MDA-MB-231	SNS-032	0.37	uM	LJP6	0.1582	0.0312	-0.2404	0.0995
MDA-MB-231	SNS-032	1.11	uM	LJP6	0.1615	0.0265	-0.2303	0.0878
MDA-MB-231	SNS-032	3.33	uM	LJP6	0.1738	0.0345	-0.2031	0.1040
MDA-MB-231	SNS-032	10	uM	LJP6	0.1731	0.0250	-0.2010	0.0815
MDA-MB-231	Afatinib	0.04	uM	LJP6	0.8563	0.0734	0.8454	0.0779
MDA-MB-231	Afatinib	0.12	uM	LJP6	0.8801	0.0281	0.8726	0.0271
MDA-MB-231	Afatinib	0.37	uM	LJP6	0.7781	0.0208	0.7551	0.0234

|<
<<
Previous
Page 75 of 166
Next
>>
>
1851 to 1875 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)